263 related articles for article (PubMed ID: 24476502)
1. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.
Stoica BA; Loane DJ; Zhao Z; Kabadi SV; Hanscom M; Byrnes KR; Faden AI
J Neurotrauma; 2014 Apr; 31(8):758-72. PubMed ID: 24476502
[TBL] [Abstract][Full Text] [Related]
2. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
3. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor.
d'Avila JC; Lam TI; Bingham D; Shi J; Won SJ; Kauppinen TM; Massa S; Liu J; Swanson RA
J Neuroinflammation; 2012 Feb; 9():31. PubMed ID: 22335939
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.
Besson VC; Zsengellér Z; Plotkine M; Szabó C; Marchand-Verrecchia C
Brain Res; 2005 Apr; 1041(2):149-56. PubMed ID: 15829224
[TBL] [Abstract][Full Text] [Related]
5. PJ34 Protects Photoreceptors from Cell Death by Inhibiting PARP-1 Induced Parthanatos after Experimental Retinal Detachment.
Dong K; Yan Y; Lu L; Wang Y; Li J; Zhang M; Ding J
Curr Eye Res; 2021 Jan; 46(1):115-121. PubMed ID: 32478624
[TBL] [Abstract][Full Text] [Related]
6. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke.
Charriaut-Marlangue C; Leconte C; Csaba Z; Chafa L; Pansiot J; Talatizi M; Simon K; Moretti R; Marchand-Leroux C; Baud O; Besson VC
Brain Behav Immun; 2018 Oct; 73():375-389. PubMed ID: 29852289
[TBL] [Abstract][Full Text] [Related]
8. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
Kabadi SV; Stoica BA; Byrnes KR; Hanscom M; Loane DJ; Faden AI
J Cereb Blood Flow Metab; 2012 Jan; 32(1):137-49. PubMed ID: 21829212
[TBL] [Abstract][Full Text] [Related]
9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
10. PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.
Chen T; Wang W; Li JR; Xu HZ; Peng YC; Fan LF; Yan F; Gu C; Wang L; Chen G
Brain Res; 2016 Aug; 1644():32-8. PubMed ID: 27157545
[TBL] [Abstract][Full Text] [Related]
11. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
Hilton GD; Stoica BA; Byrnes KR; Faden AI
J Cereb Blood Flow Metab; 2008 Nov; 28(11):1845-59. PubMed ID: 18612315
[TBL] [Abstract][Full Text] [Related]
12. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation.
Wani WY; Sunkaria A; Sharma DR; Kandimalla RJ; Kaushal A; Gerace E; Chiarugi A; Gill KD
Neuroscience; 2014 Jan; 258():1-15. PubMed ID: 24231740
[TBL] [Abstract][Full Text] [Related]
13. Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide.
Won SJ; Choi BY; Yoo BH; Sohn M; Ying W; Swanson RA; Suh SW
J Neurotrauma; 2012 May; 29(7):1401-9. PubMed ID: 22352983
[TBL] [Abstract][Full Text] [Related]
14. Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1.
Xu J; Wang H; Won SJ; Basu J; Kapfhamer D; Swanson RA
Glia; 2016 Nov; 64(11):1869-78. PubMed ID: 27444121
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
16. Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase.
Luo T; Wu J; Kabadi SV; Sabirzhanov B; Guanciale K; Hanscom M; Faden J; Cardiff K; Bengson CJ; Faden AI
Anesthesiology; 2013 Dec; 119(6):1370-88. PubMed ID: 24121215
[TBL] [Abstract][Full Text] [Related]
17. Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.
Besson VC
Br J Pharmacol; 2009 Jul; 157(5):695-704. PubMed ID: 19371326
[TBL] [Abstract][Full Text] [Related]
18. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.
Xu X; Chua CC; Zhang M; Geng D; Liu CF; Hamdy RC; Chua BH
Brain Res; 2010 Jul; 1343():206-12. PubMed ID: 20451505
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.
Piao CS; Loane DJ; Stoica BA; Li S; Hanscom M; Cabatbat R; Blomgren K; Faden AI
Neurobiol Dis; 2012 Jun; 46(3):745-58. PubMed ID: 22426396
[TBL] [Abstract][Full Text] [Related]
20. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.
Hamby AM; Suh SW; Kauppinen TM; Swanson RA
Stroke; 2007 Feb; 38(2 Suppl):632-6. PubMed ID: 17261705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
